title: Is intermittent short-course anti-TB regimen as efficient and safe as daily anti-TB regimen for treating childhood TB?
abstract: Childhood tuberculosis (TB) is a common clinical condition in low- and middle-income nations like India where TB is endemic. Different guidelines vary in the recommendations on treatment regimes for childhood TB. Apart from clinical outcomes the decision to use one regimen over another also has an implication in the form of health system burden. The evidence summary presents the comparison between the intermittent regimens with the daily anti-TB regimen for childhood TB.
authors.affiliation: Executive Editor, Journal of Family Medicine and Primary Care, New Delhi, India.
authors.forename: Soumyadeep
authors.initials: S
authors.lastname: Bhaumik
keywords: Adolescent; antitubercular agents; child; drug administration schedule; drug therapy; humans; randomized controlled trials as topic; tuberculosis